SCHEMBL2834174

SCHEMBL2834174

NC(C(=O)c1ccc(-c2cccc([N+](=O)[O-])c2)cc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
EIF4E P06730 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
HDAC2 Q92769 1/20 0.42
CNR1 P21554 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NQO2 P16083 1/20 0.40
TSHR P16473 2/20 0.40
AKR1C3 P42330 2/20 0.40
AKR1C2 P52895 2/20 0.40
ALDH1A1 P00352 1/20 0.40
PLG P00747 1/20 0.40
PLAU P00749 1/20 0.40
PLAT P00750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2839115 0.99 CYP3A4 (0.43) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL2836748 0.81 CYP3A4 (0.51) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL7813356 0.81 CYP3A4 (0.51) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL2836676 0.80 DPP4 (0.45) CYP3A4CYP2D6PLAUPTPN5CYP1A2
SCHEMBL3806617 0.80 HSD17B10 (0.63) EIF4ECNR1HSD17B10TSHRALDH1A1
Hydrochloric Acid SCHEMBL2833832 0.77 FFAR1 (0.44) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL3799957 0.77 MEN1 (0.45) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL2839835 0.76 RXRA (0.55) SLC6A2SLC6A4SLC6A3CNR1PTPN5
SCHEMBL27889371 0.73 TSHR (0.68) CYP3A4MMP2MMP9MMP8HDAC2
SCHEMBL3765312 0.72 TP53 (0.67) MMP2MMP9MMP8HDAC2NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS HOFFMANN-LA ROCHE, INC. 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS GFPT1, CEPT1, SLC18A2 CYP3A4 1043/4885CYP2D6 767/4885SLC6A2 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.